Detection of Minimal Residual Disease in Hematopoietic Tissues
- 1 December 1995
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 770 (1), 242-261
- https://doi.org/10.1111/j.1749-6632.1995.tb31060.x
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow TransplantationNew England Journal of Medicine, 1994
- Induction of Graft-versus-Host Disease as Immunotherapy for Relapsed Chronic Myeloid LeukemiaNew England Journal of Medicine, 1994
- Detection of Tumor Contamination of Peripheral Stem Cells in Patients with Lymphoma Using Cell Culture and Polymerase Chain Reaction TechnologyJournal of Hematotherapy, 1994
- Preliminary Results of Treatment with Filgrastim for Relapse of Leukemia and Myelodysplasia after Allogeneic Bone Marrow TransplantationNew England Journal of Medicine, 1993
- Gene-marking to trace origin of relapse after autologous bone-marrow transplantationThe Lancet, 1993
- Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patientsThe Lancet, 1992
- Micrometastatic tumour cells in bone marrow of patients with gastric cancer: Methodological aspects of detection and prognostic significanceEuropean Journal of Cancer and Clinical Oncology, 1991
- Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes.Proceedings of the National Academy of Sciences, 1989
- Human c-myb protooncogene: nucleotide sequence of cDNA and organization of the genomic locus.Proceedings of the National Academy of Sciences, 1986
- Utilization of a human tumor cloning system to monitor for bone marrow involvement in children with non-Hodgkin's lymphomaCancer, 1984